Prevalence, location, and determinants of valvular calcifications in Congolese patients on chronic hemodialysis : a multicenter cross-sectional study

• Published in: Saudi journal of kidney diseases and transplantation 2020-09, Vol.31 (5), p.927-936
• Main Authors: Lubenga, Yves N., Engole, Yannick M., Mboliasa, Marie France, Nlandu, Yannick M., Makulo, Jean-Robert R., Mokoli, Vieux M., Kahindo, Charles K., Kadima, Evariste M., Longo, Augustin L., Nkodila, Aliocha, Bukabau, Justine B., Lepira, François B., Nseka, Nazaire M., Sumaili, Ernest K.
• Format: Article
• Language: English
• Subjects: Congo (Kinshasa); Cross-sectional studies; Health aspects; Hemodialysis; Medical research; Mortality; Prevalence studies (Epidemiology); Risk factors; Venture capital; Venture capital companies
• ISSN: 1319-2442; 2320-3838
• DOI: 10.4103/1319-2442.301199

Valvular calcifications (VCs) are one of the major cardiovascular complications in patients on chronic hemodialysis (HD) due to its prevalence and predictive morbidity and mortality. The current study assessed the prevalence, location, and risk factors of VC among chronic HD Congolese patients in Kinshasa. This observational study involved three HD centers in Kinshasa between March and August 2016. Consecutive consenting adults on maintenance HD for at least six months were recruited. VCs were defined as a luminous echo on one or more cusps of the aortic or mitral valve. Risk factors of VC were determined by multivariate analysis. Sixty patients (mean age: 52.5 ± 15.9 years) were enrolled. The mean serum calcium and phosphorus were7.9 ± 1.3 mg/dL and 5.7 ± 1.7 mg/dL, respectively. VCs were encountered in 38% of the whole group in aortic and mitral valvular location in 64% and 23%, respectively. Hypertension, age >60 years, tobacco use, and hyperphosphatemia were independently associated with VC. Despite a young age of patients, VCs were a common finding and associated with both traditional and chronic kidney disease-specific risk factors.